People

Courtney McKnight
Courtney McKnight, DrPH
NYU School of Global Public Health - Clinical Assistant Professor
Education
DrPH, Public Health, CUNY Graduate Center
MPH, Public Health, Hunter College
BA, Sociology, Rutgers University
Research Interests
Substance use policy, Health care access for people who use drugs
BIO
Courtney McKnight has over 20 years of public health experience, with a significant background in socio-behavioral research related to substance use, as well as field experience as a harm reduction service provider. Dr. McKnight served as the Assistant Director of Research at the Chemical Dependency Institute (CDI) at the Icahn School of Medicine at Mount Sinai. During her tenure at CDI, Dr. McKnight served as co-investigator and project director on numerous federally funded research studies, including evaluations of health promotion programs, interventions to increase access to medical care, and investigations of the drivers that contribute to disparate rates of disease. In addition to her professional experience, Dr. McKnight completed her doctoral degree in Public Health at the CUNY Graduate Center. Her dissertation was focused on investigating the impact of Medicaid coverage of methadone and buprenorphine on treatment access for opioid dependent Medicaid beneficiaries. Dr. McKnight’s current research interests include substance use policy and health care accessibility for people who use drugs.
Projects
Principal Investigator, Risk Factors for AIDS among Persons Who Inject Drugs: HIV and COVID-19. Active
Principal Investigator, Xylazine Test Strip Use and HIV Risk Behaviors Among People Who Inject Drugs. Active
Principal Investigator, Comparison of Stigmatization of Monkeypox, Injecting Drug Use, HIV/AIDS, and COVID-19. Completed
Principal Investigator, Examination of Opioid Overdose Prevention Behaviors Among People Who Use Drugs. Completed
Principal Investigator, Knowledge and Perceptions of Fentanyl Among Opioid Users and Service Providers. Completed
Principal Investigator, Poly Drug Use and Overdose Risk Among Individuals Using Methamphetamine and Opioids. Completed
Publications

Recent

Des Jarlais DC, McKnight C, Weng CA, Feelemyer J, Tross S, Raag M, Org G, Talu A, Uuskula A (2023).
Field testing the “Avoid the Needle” intervention for persons at risk for transitioning to injecting drug use in Tallinn, Estonia and New York City, USA
AIDS and Behavior, 27 (11), 3767-3779. doi: 10.1007/s10461-023-04094-0. PMCID: PMC10227783.

Des Jarlais DC, Weng CA, Feelemyer J, McKnight C (2023).
Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City: Prevalence, risk factors
Drug and Alcohol Dependence Reports, 8, 100171. doi: 10.1016/j.dadr.2023.100171. PMCID: PMC10247299.

Khezri M, Tavakoli F, Schwartz S, Karamouzian M, Sharifi H, McKnight CA, Des Jarlais D, Baral S, Shokoohi M (2023).
Global epidemiology of abortion among female sex workers: A systematic review, meta-analysis, and meta-regression
Annals of Epidemiology, 85, 13-37. doi: 10.1016/j.annepidem.2023.06.022.

Palayew A, Knudtson K, Purchase S, Clark S, Possehl L, Healy E, Deutsch S, McKnight CA, Des Jarlais D, Glick SN (2023).
HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA
Harm Reduction Journal, 20 (1), 102. doi: 10.1186/s12954-023-00839-1. PMCID: PMC10394878.

McKnight C, Weng CA, Reynoso M, Kimball S, Thompson LM, Des Jarlais D (2023).
Understanding intentionality of fentanyl use and drug overdose risk: Findings from a mixed methods study of people who inject drugs in New York City
International Journal of Drug Policy, 118, 104063. doi: 10.1016/j.drugpo.2023.104063. PMCID: PMC10524892.

Dr. McKnight's MyBibliography Profile
Selected Press